GET DAILY SIGNALSWhy Is Ichor Holdings (ICHR) Stock Up +9.38% Today?
Key Takeaways
- ICHR climbed 9.38% to $30.66 in intraday trading, rebounding from a prior close of $28.03.
- The move follows a steep multi-session post-earnings selloff, leaving the stock in deeply oversold territory and primed for a relief bounce.
- Third-quarter results delivered a strong earnings beat and margin expansion, even as revenue narrowly missed and supply-chain constraints weighed on sentiment.
- Fresh analyst Buy reaffirmations from Stifel and TD Cowen supported the recovery narrative.
- Broader semiconductor equipment demand, tied to AI-driven investment in advanced etch and deposition tools, remains a key backdrop.
- Traders are watching whether the rebound holds and whether ICHR can reclaim key technical levels.
- For deeper analysis, explore Price Targets, Earnings, and Forecast pages dedicated to this ticker.
- Curious how automated strategies are positioning across the market? Explore Trending AI Robots.
Opening Summary
ICHR — Ichor Holdings, Ltd., a designer and manufacturer of gas and chemical fluid-delivery subsystems and components used in semiconductor capital equipment — surged 9.38% on Thursday, trading around $30.66 versus a previous close of $28.03. The rebound marked a sharp reversal after several down sessions, and markets attributed the gain to bargain hunting in an oversold name, reinforced by fresh analyst support and an underlying earnings story that highlighted margin expansion and upbeat forward guidance.
An Oversold Bounce After a Post-Earnings Selloff
The most immediate driver behind Thursday's price rally appears to be a technical and sentiment-driven rebound. ICHR had fallen sharply in the days following its November 2 earnings report, with the stock losing roughly 17% in the prior session alone. That slide pushed the shares into deeply oversold territory, leaving them well below both their 50-day and 200-day moving averages. With short-term sellers exhausted and valuation reset to multi-month lows, dip buyers stepped in, triggering a classic relief rally rather than a fundamentally new catalyst.
Earnings-Driven Move: Strong Margins, Upbeat Guidance
Beneath the bounce sits a fundamentally stronger quarter than the share-price decline suggested. For its fiscal third quarter, ICHR reported non-GAAP earnings of $0.63 per share, well above consensus estimates near $0.45, while revenue rose 37.4% year over year to $328.7 million. Although the top line narrowly missed expectations, non-GAAP gross margin expanded to 16% — above management's guided range — driven by favorable product mix, rising proprietary component content, and improved manufacturing efficiency. Management also guided fourth-quarter revenue to a range of $345 million to $365 million and non-GAAP EPS of $0.65 to $0.75, implying roughly 8% sequential growth and full-year 2026 revenue growth near 30%. That earnings-driven margin expansion and confident outlook provided a fundamental anchor for Thursday's recovery.
Analyst Support Reinforces the Recovery
Adding fuel to the rebound, sell-side firms reiterated constructive views on the shares. Stifel reaffirmed a Buy rating on ICHR with a $76 price target, while TD Cowen maintained a Buy rating with an $80 target. These reaffirmations signaled that, despite near-term supply-chain friction and recent price-target adjustments across the Street, core demand for the company's fluid-delivery systems remained intact. The analyst commentary helped counterbalance earlier concerns and lent credibility to the case for buying the dip.
Market Context and Trading Activity
The advance unfolded against a backdrop of persistent strength in demand for advanced etch and deposition equipment tied to AI infrastructure build-outs — a theme that underpins ICHR's order book and its growing exposure to gate-all-around architectures and advanced DRAM manufacturing. Trading activity was active, with elevated volume accompanying the recovery, consistent with heightened investor repositioning after the sharp drawdown. While the company acknowledged ongoing component shortages that have constrained shipments — particularly in valves, fittings, and flow-control products — management emphasized that it is prioritizing higher-margin component sales and expanding proprietary content, which now exceeds 30% of gas systems sold and is expected to approach 35% by year-end.
What Comes Next for ICHR
Looking ahead, investors will monitor whether ICHR can sustain its rebound and build on management's guidance for sequential revenue growth in every quarter of 2027. Key factors include the pace at which supply-chain constraints ease, the ramp of proprietary component and flow-control product revenue, and the company's continued manufacturing expansion in Malaysia and Mexico. Risks remain: commercial space shipment delays, component availability, and a moderating incremental gross margin into the fourth quarter could temper the recovery. Any broader rotation within semiconductor equipment names will also shape sentiment. As the stock consolidates from oversold levels, the durability of Thursday's rally will be tested by both company-specific execution and the wider sector's momentum.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of automated bots covering thousands of tickers, with each bot differentiated by its strategy, timeframe, performance metrics, and traded symbols. Only the strongest performers are featured in this section, giving traders a focused view of strategies adapting well to today's environment. Explore the page to see which AI-driven approaches are currently leading.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ICHR's Stochastic Oscillator remains in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICHR as a result. In 72 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 38 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.340) is normal, around the industry mean (5.670). P/E Ratio (-26.466) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. ICHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment
Advertisement